# OnCo record paper-icc-2022-arber-blood-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-icc-2022-arber-blood-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-icc-2022-arber-blood-2022" ;
  schema:name "International Consensus Classification of myeloid neoplasms and acute leukaemias (2022)"@en ;
  schema:description "A parallel classification to the WHO 2022 edition from an international expert group, which among other changes creates an MDS/AML category for 10 to 19 percent blasts and gives TP53-mutated disease its own entities."@en ;
  schema:url <https://onco.cc/key-papers/paper-icc-2022-arber-blood-2022/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://doi.org/10.1182/blood.2022015850>, <https://pubmed.ncbi.nlm.nih.gov/35767897/> ;
  schema:sameAs <https://doi.org/10.1182/blood.2022015850> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Arber DA, Orazi A, Hasserjian RP, et al." ;
  onco:cancers <https://onco.cc/cancers/mds-higher-risk/> ;
  onco:journals <https://onco.cc/journals/blood/> .